View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

B&S Group: FY24 results and FY25 outlook in line. UCB: Peer Incyte fails to impress in Hidradenitis Suppurativa

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

B&S Group: Preview - meeting its guidance. Randstad: Highlights of corporate roadshow. Staffing: US temp volume trend stable but still soft in Feb; upward revisions to Jan/Dec. Vopak: Ahead of its CMD

Robert Jan Vos
  • Robert Jan Vos

B&S Group S.A. : Market reaction too bitter given solid Q3 and reassur...

>Q3 2024 sales 3.6% higher than our above-market expectation - B&S Group reported a solid Q3 2024, in our view. Sales came in 3.6% higher than our estimate, which we think was the highest in the market. In all divisions except retail, organic sales growth was either higher than expected or significantly better than forecast. Management’s tone on the business was generally positive, and the same applies to the comments about Q4 2024. We forecast 7.1% sales growth in Q4...

Marc Zwartsenburg ... (+3)
  • Marc Zwartsenburg
  • CEFA
  • Tijs Hollestelle

B&S Group/Growing fast in difficult market conditions/BUY

The B&S 3Q24 trading update surprised positively on top line performance but disappointed somewhat on costs. 3Q24 revenue was c.8% above our expectations and growth was driven by most business segments. B&S indicated that gross margin decreased in 3Q24, while we expected flat YoY gross margin. Wage costs also increased, this in line with management expectations and our own. As a consequence B&S expects FY24 EBITDA margin to be in the lower half of the 5-6% guidance. We raise our FY24 revenue est...

Jean Danjou
  • Jean Danjou

ODDO BHF Small & MIDCAP MORNING NEWS - 11/11/2024

Springer Nature is one of the world’s leading professional publishing companies. Its highly recurring revenue base and strong market position, good FCF generation and a deleveraging balance sheet should lead to a rerating, we believe. We initiate coverage with an Outperform and a TP of €33. - ...

Jean Danjou
  • Jean Danjou

ODDO BHF Small & MIDCAP MORNING NEWS - 11/11/2024

Springer Nature is one of the world’s leading professional publishing companies. Its highly recurring revenue base and strong market position, good FCF generation and a deleveraging balance sheet should lead to a rerating, we believe. We initiate coverage with an Outperform and a TP of €33. - ...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

B&S Group: Strong top line, margin guidance lowered due to high costs. Staffing: France September trend weaker on tough comps, October outlook stable

Robert Jan Vos
  • Robert Jan Vos

B&S Group S.A. : Solid sales in Q3 2024, but EBITDA outlook marginally...

>Sales beat expectations in Q3 2024; gross margin under pressure - B&S Group reported net sales of € 609.1m in Q3 2024. Organic sales growth amounted to 11.8% in the quarter. Our estimates were € 588m and 7.8%, respectively. There was no consensus available, but from investors we understood that our estimates were the highest. All segment, except the retail segment, strongly outperformed our forecasts. Management added that turnover increased across all segments, whil...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Adecco: 3Q24 miss; stabilising trends in 3Q24 and into 4Q24; accelerating cost savings. B&S Group: 3Q24 preview - liquor bottoming into 4Q24? Coca-Cola Europacific Partners: Almost the real thing. D'Ieteren: Belgian October car registrations down 5.5%, VW down 11%. Kinepolis: Oct US/Canada box office at 59% of pre Covid level, France recovery to 78%. Recticel: 3Q24 compares well with Kingspan. Renewi: 1H25 preview - battling cost inflation with self help. Syensqo: Slight beat on 3Q...

Robert Jan Vos
  • Robert Jan Vos

B&S Group S.A. : We reiterate our Outperform, mainly on valuation

>Solid operational results show B&S Group is on track for its goals in 2024 - Following B&S Group’s H1 2024 results (19 August), we now put through some changes in our model. As a reminder, the group’s H1 2024 results were slightly better than our forecasts. Organic sales growth came in at 4.2% (ABNe: 2.6%) in H1 2024. The Personal Care and Food divisions outperformed our revenue expectations. On divisional EBITDA, we conclude that Personal Care reported strongly, an...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch